CommonSpirit Health Physician Enterprise

New article in JAMA asks the age-old question: Are routine EKGs in asymptomatic healthy adults helpful? Dr. McGinn and guest experts review the evidence and latest guidelines. Guests:Dr. Ankita SagarSystem Vice President for Clinical Standards and Variation Reduction, Physician EnterpriseAssociate Clinical Professor of Medicine, Creighton UniversityDr. Gary GreensweigSystem Senior Vice President and Interim Chief Medical & Quality Officer (CMQO), CommonSpirit HealthStudies referenced: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2820721?guestAccessKey%3Db122716f-826f-4a09-82cb-e32aa6fa0f43%26&sa=D&source=calendar&ust=1733927688755673&usg=AOvVaw39iMVRrJYFLIVN1EdHa6mlGuidelines referenced:https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-risk-screening-with-electrocardiographyhttps://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/cw-ekg.html

This Grand Rounds session discusses delirium among older adults, the first in a series of age-friendly initiative sessions discussing the care approach for aging patients.Moderators:John Morelli, MD, System VP Acute Care Clinical Service LineThomas Frederickson, MD, FACP, SFHM, MBA, System VP Hospital Medicine OperationsSpeaker:Rajesh Tampi, MD, MS, DFAPA, DFAAGP, Professor and Chairman, Department of Psychiatry, Creighton University School of MedicinePanelists:Nikhil Seth, MD, Assistant Professor, Baylor College of MedicineConnor Rowan, PharmD, Clinical Pharmacist with Geriatric Expertise, Virginia Mason Franciscan Health

Implementing SDOH/Health-Related Social Needs Screening and Management in Ambulatory Care. Our speaker for the session is Kevin Fiori, MD, MPH, MS, FAAP, from Montefiore Einstein, a premier academic health system known as a pioneer in the space and one of the largest value-based providers for health-related social needs assessment and value-based whole-person care.Panelist:Corey Karlin-Zysman, MD, Chief of the Physician EnterpriseBarbara J. Martin, PhD, ACNP-BC, MPH, System Senior Vice President, Advanced PracticeLearning Objectives:- Summarize current evidence, guidance and rationale for health-related social needs (HRSN) screening in clinical practice.- Describe lessons learned from Montefiore Health System's experience implementing and scaling HRSN screening and navigation support.- Identify future directions for integrating HRSN screening and support in health care delivery.

Physician Enterprise Grand Rounds session discussing best practices for Type 2 Diabetes Mellitus Management.Our speakers for the session are Mandeep Bajaj, MBBS, Vice Chair for Clinical Affairs and a Professor in the Department of Medicine at Baylor College of Medicine, and Avin P. Pothuloori, MD, Assistant Professor of Medicine at Creighton University School of Medicine.PanelistDebra Rockman, RN, MBA, System Vice President of Ambulatory Quality, CommonSpirit Health

Guest: Dr. Hana El Sahly, Professor, Kyle and Josephine Morrow Chair, Molecular Virology and Microbiology Vaccine and Treatment Evaluation Unit, Baylor College of MedicineDiscuss the latest updates and clinical implications of Bird Flu/H5N1 and the measles outbreak. Bird flu/H5N1- Overview- Infection rates- Risk of transmission to humans- Prevention- Surveillance Measles- Overview- Outbreak status compared to prior years- Infection rates- Vaccine recommendationsResources: https://www.nejm.org/doi/full/10.1056/NEJMoa2414610https://www.cdc.gov/bird-flu/situation-summary/index.htmlhttps://www.cdc.gov/measles/hcp/vaccine-considerations/index.html

Our speaker for the session is Summer Peregrin, PharmD, Ambulatory Clinical Pharmacist at Dignity Health Medical Group — Arizona, and one of the authors of the Opioid Toolkit for CommonSpirit Health.Learning ObjectivesReview the current state of the opioid epidemicRecognize signs and symptoms of a potential opioid overdoseBuild greater understanding of naloxone and its use to treat an opioid overdoseSummarize best practices in emergency response to an opioid overdosePanelistsShawna Sharp, RN, System Director Clinical Transformation, Physician EnterpriseMarijka Grey, MD, MBA, FACP, System Vice President Ambulatory Transformation & Innovation, Physician Enterprise

Our speaker for the session is Justin Reynolds, MD, the Medical Director of Liver Transplant and Chief of Hepatology at the St. Joseph's Hospital and Medical Center in Phoenix, Arizona. Learning Objectives:Provide updates to the current landscape of steatotic (fatty) liver disease, including recent nomenclature changes.Learn about treatment options for individuals with MASLD/MASH including when to refer to specialty care.Discuss the epidemic of MASLD/NAFLD, as well as the increasing burden of MASH/NASH.Learn methods to assess individuals for at-risk MASH, emphasizing non-invasive tests and their role in clinical care.

In this episode of the 5-Minute Check In with Dr. Thomas McGinn, our myth-busting team takes on two popular topics submitted by our providers: 5G radiation: Whether you are near a cell phone tower or holding a cell phone too close to your head, is 5G radiation harmful?Vitamin D: this supplement is marketed as a cure all for preventing falls, fractures, and even dementia. Should patients be routinely screened if they have no indication for deficiency? Watch as we compare popular beliefs to the latest evidence. Links: 5G Radiation  https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/cell-phones-fact-sheet#is-the-radiation-from-cell-phones-harmfulhttps://www.cancer.org/cancer/risk-prevention/radiation-exposure/cellular-phone-towers.htmlhttps://pubmed.ncbi.nlm.nih.gov/35350069/  Vitamin Dhttps://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-deficiency-screeninghttps://www.acpjournals.org/doi/full/10.7326/M14-1659?download=true&journalCode=aim  

Hear from three of our Physician Enterprise Academic Excellence Award Winners as they share their award winning papers for 10 minutes, before breaking into a panel discussion/Q&A.Una Lee, MDUrology Physician LeadVirginia Mason Franciscan HealthCategory: Practice Innovation Paper Title: Creating an Extraordinary Experience for Women Undergoing Cystoscopy: A Patient-Centered Approach to Process ImprovementRachel Bond, MD, FACCSystem Director, Women's Heart Health Dignity Health in ArizonaCreighton University School of MedicineCategory: Health Equity Research Paper Title: Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart AssociationAnne Kennard, DOAssociate Program Director, OB/GYN ResidencyChief, Integrative and Lifestyle MedicineMarian Regional Medical Center, Santa Maria CACategory: Medical Humanities    Paper Title: Contemplative medicine: A practical approach to "Well-Being 2.0" in medicine

In this episode of the 5-Minute Check In with Dr. Thomas McGinn, Infectious Disease expert Dr. Renuga Vivekanandan joins us for an update on the winter virus season.Topics Discussed:InfluenzaCOVID-19RSVPneumoniaDisease X*Guest: Renuga Vivekanandan, MD, Infectious Disease Expert, Division VP and CMO Physician Enterprise - Midwest, Professor, Associate Dean for Clinical Affairs, Creighton University School of Medicine*Disease X was identified as malaria after this recording. Learn more:https://www.cbsnews.com/news/congo-mystery-disease-identified-severe-malaria-deaths-women-children/

Guests: Dr. Ankita Sagar and Dr. Thomas Frederickson, System VP Hospital Medicine, CommonSpirit Health and Assistant Clinical Professor of Medicine, Creighton University School of Medicine. In this episode our myth-busting team discusses the use of PRN antihypertensive medication in hospitalized patients without hypertensive emergencies.Watch as we compare popular beliefs to the latest evidence:Studies referenced: https://doi.org/10.1161%2FHYPERTENSIONAHA.121.17279https://doi.org/10.1001/jamainternmed.2019.3007

Osteoporosis significantly impacts morbidity and mortality in the U.S., with approximately 12.3 million adults (USPSTF) in the United States aged 50 and over expected to be living with the disease. Osteoporotic fractures result in severe consequences such as functional impairment, chronic pain, reduced quality of life, and loss of independence. Furthermore, the clinical and economic burden of osteoporosis is substantial, with annual costs projected to be $25.3 billion by 2025 (AJMC).The U.S. Preventative Task Force (USPSTF) recommends screening and treatment of osteoporosis in adults. Accordingly, CommonSpirit Health, Physician Enterprise has adopted the evidence based guidelines of professional societies, including American College of Physicians (ACP), American Association of Clinical Endocrinologists (AACE), and Endocrine Society, on screening and treatment to prevent osteoporotic fractures. Speakers:Kavita Chawla, MD, MHA, FACP, Primary Care Physician, Kirkland Medical Center, Virginia Mason Franciscan HealthBryan C Jiang, MD, Internal Medicine Endocrinology, Diabetes and Metabolism, Baylor College of Medicine Houston, TexasPanelist:Anne Wright, DMSc, MPAS, PA-C, DFAAPA, System Director Advanced Practice Ambulatory Care, CommonSpirit Health

Topics covered: - Defining antimicrobial stewardship- New randomized clinical trial looking at how stewardship prompts improve antibiotic selection for pneumonia- Resources and how CommonSpirit Health is taking action and addressing this important topicGuest expert: Dr. Renuga Vivekanandan, Infectious Disease Expert, Division VP and CMO Physician Enterprise - Midwest, Professor, Associate Dean for Clinical Affairs, Creighton University School of Medicine

Infectious Disease expert Dr. Renuga Vivekanandan joins us for a preview of what to expect this season. Topics covered:- Viruses- Influenza- COVID-19- RSV- West Nile- MPox - VaccinesGuest: Dr. Renuga Vivekanandan, infectious Disease expert and Division VP and CMO Physician Enterprise - Midwest, Professor, Associate Dean for Clinical Affairs, Creighton University School of Medicine.

Back by popular demand, our mythbusting team takes looks at two new health topics making headlines and compares popular beliefs to the latest evidence: Is exercise as effective as other treatments to help depression?Meta-analysis:  https://www.bmj.com/content/384/bmj-2023-075847Do tattoos cause lymphoma?Study: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00228-1/fulltextPlus a discussion on correlation vs. causation Guest: Dr. Ankita SagarSystem Vice President for Clinical Standards and Variation Reduction, Physician Enterprise and Associate Clinical Professor of Medicine, Creighton University Previous Myth-Busting EpisodesAre full body, preventative scans helpful or harmful for healthy individuals?https://www.buzzsprout.com/1903646/15388164Fasting and Statins: Do statins cause muscle aches and is it necessary to fast before labs?https://www.buzzsprout.com/1903646/13919434Water Consumption and Vegetarian Diets: How much water do we really need and are vegetarian or vegan diets truly healthy?https://www.buzzsprout.com/1903646/14691788

Components of social connection are associated with mortality, but research examining their independent and combined effects in the same dataset is lacking. That has now changed thanks to a recent study published in BMC Medicine. We're joined by the primary author of that study to discuss the results and to get his perspective on social connectivity, loneliness and isolation and the impact on mortality. Discussed:Subjective and objective types of social connectionAnalysis of more than 458,000 participants with full data from the UK Biobank cohort linked to mortality registersWhat types of loneliness and social isolation are linked to a higher risk of death Potential implications for screeningGuest: study author and Clinical Research Fellow at the University of Glasgow Dr. Hamish Foster References: Study: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-03055-7 Surgeon General Advisory: https://www.hhs.gov/sites/default/files/surgeon-general-social-connection-advisory.pdfSurgeon General Report on Social Connection: www.hhs.gov/sites/default/files/sg-social-connection-general.pdf

Back by popular demand, the latest myth-busting episode of the 5-Minute Check In with Dr. McGinn takes a closer look at another popular and controversial topic: Are full body, preventative scans helpful or harmful for healthy individuals?Watch as we separate fact from fiction and compare popular beliefs to the evidence. Previous Myth-Busting EpisodesMyth-Busting — Fasting and Statins  Do statins cause muscle aches and is it necessary to fast before labs?https://www.buzzsprout.com/1903646/episodes/13919434-5-minute-check-in-mythbusting-headlines-and-common-misconceptionsMyth-busting - Water Consumption and Vegetarian DietsHow much water do we really need and are vegetarian or vegan diets truly healthy?https://www.buzzsprout.com/1903646/episodes/14691788-health-myth-or-fact-comparing-clinical-beliefs-to-the-evidence-episode-2

Learning Objectives (and corresponding articles): Identify medications best avoided by older adults in most circumstances or specific clinical scenarios (JAGS)Discern the benefits, harms, and efficacy of different smoking cessation pharmacotherapies and e‐cigarettes (Annals of Internal Medicine)Evaluate the effectiveness, harms, and benefits of newer diabetic medications on mortality, cardiovascular and renal outcomes (Cochrane Review)Understand the utilization of eGFRcr versus eGFR based on creatinine and cystatin C levels (eGFRcr-cys) in older adults (Annals of Internal Medicine)Quantify trends in racial/ethnic disparities in TB incidence among U.S.-born persons (Annals of Internal Medicine)Recognize the well-being and turnover rates of physicians and nurses as well as actionable factors on adverse clinician outcomes (JAMA)The benefits of puppies: https://psycnet.apa.org/fulltext/2023-97081-001.htmlPresenter:Ankita Sagar, MD, MPH, FACP, System Vice President, Clinical Standards and Variation Reduction, Associate Clinical Professor of Medicine at Creighton University School of MedicineGuests:Barbara Martin, PhD, System Senior Vice President, Advanced PracticeCorey Karlin Zysman, MD, System Senior Vice President, Physician Enterprise, Arizona and Nevada

Learning Objectives:-Review the history and flawed assumptions in the use of race and how race-specific PFT reference equations might lead to health disparities.-Understand the evidence behind the recommendation to use race-neutral reference equations.-Review the quantitative impact of switching from race-specific to race-neutral reference equations.-Assess the many remaining gaps in our understanding of how to use pulmonary function tests to improve health.Speakers:Nirav Bhakta, MD, Associate Professor of Medicine, Pulmonary and Critical Care at the University of California, San FranciscoDr. Bhakta is a national thought leader and Vice-chair of the American Thoracic Society Pulmonary Function Testing Committee. Dr. Bhakta co-chaired the ATS workshop on race and PFTs that led to the publication of the 2023 ATS Statement.Panelists:Thomas R. Vendegna, MD, Pulmonology and Critical Care, CMO French Hospital Medical Center (Facilitator)Jeff Sippel, MD, Critical Care Medicine, UC HealthRobert Wiebe, MD, CMO, CommonSpirit HealthSuchitra Pilli, MD, Interventional Pulmonology and Critical Care, Medical Director for Respiratory Therapy, CHI Health Omaha, Assistant Professor, Creighton UniversityGary Greensweig, DO, Chief Physician Executive, Physician Enterprise, CommonSpirit HealthAnkita Sagar, MD, System Vice President, Clinical Standards and Variation Reduction, Physician Enterprise, Associate Clinical Professor of Medicine at Creighton University School of Medicine

First-of-its-kind medication shows promise for liver disease patientsMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is estimated to affect nearly one-quarter of adults in the United States. Nonalcoholic steatohepatitis (NASH) is a form of MASLD that can cause liver fibrosis, cirrhosis, liver failure, and liver cancer. It is one of the most common reasons why patients need liver transplants.The FDA recently granted accelerated approval to resmetirom, the first medication to treat nonalcoholic steatohepatitis (NASH) and liver fibrosis. Prior to the FDA approval, there were no approved drugs to treat this diseaseIn this 5-minute check in, we review the promising phase 3 data from a randomized trial that led to FDA approval including the results, the implications for patient care, and the potential to transform the landscape of NASH managementGuest: Dr. Justin Reynolds, Associate Professor, Creighton University School of Medicine, Gastroenterologist and Transplant Hepatologist, St Joseph's Hospital and Medical Center Transplant Center in Phoenix, Arizona.Study: https://www.nejm.org/doi/10.1056/NEJMoa2309000

This special session will explore the transformative impact of gene therapy for sickle cell disease. The session includes the firsthand perspective of Ms. Victoria Gray.  Ms. Gray is the first patient in the United States to undergo revolutionary CRISPR treatment for Sickle Cell Disease. After decades of pain and struggle, Ms. Gray's CRISPR procedure has not only modified her affected cells, she has not needed any transfusions and has not experienced any pain attacks.  In addition to Ms. Gray's story, the session will provide a brief update on gene therapy and treatment of Sickle Cell Disease. The session faculty will also discuss the ethical considerations surrounding patient selection, cost of gene therapy, and policies currently in place/needed for ensuring equitable access.The session is meant to be an introduction to the implications the gene therapy revolution may have on individuals, health care organizations, and the broader landscape of health care delivery in the United States.Watch our recent 5-Minute Check In about Sickle Cell Disease: https://youtu.be/clUcAR_tPbw?si=cW6Df4i6_S0bnbOa

As part of our ongoing commitment to advancing health equity and evidence-based medicine, CommonSpirit Health has been leading the way in adjusting the use of race and ethnicity in various clinical calculators, first with eGFR and now with pulmonary function tests. In this 5-minute check in, we take a look at:The history and flawed assumptions in the use of race and how race-specific PFT reference equations lead to health disparity including misdiagnosis and inappropriate treatment.Updated recommendations from the American Thoracic Society (ATS) to remove the use of race in the evaluation and interpretation of spirometry in favor of race-neutral equations. The application of race-neutral GLI equations on clinical decision-making and overall impact on patient outcomes.The next steps CommonSpirit is taking to transition the equation to race-neutral. Supporting articles:https://www.atsjournals.org/doi/full/10.1164/rccm.202302-0310SThttps://www.acpjournals.org/doi/10.7326/M23-2960Guest: Dr. Thomas Vendegna, Pulmonologist and Critical Care and CMO French Hospital Medical Center

This is our 50th episode! Thanks to everyone that has participated as a guest or has watched our videos.In this episode of the 5-Minute Check In with Dr. McGinn, we take a closer look at CommonSpirit Health's updated breast cancer screening guidelines.Topics discussed in this episode include:- Reviewing screening best practices on risk stratification for breast cancer into average, intermediate, and high risk- Screening recommendations - Integrating the criteria into the process of care- Screening approach for patients with high density breast tissueThe episode also includes discussion of the ways in which CommonSpirit is leveraging technology to identify patients eligible for breast cancer screening.Guests:Ankita Sagar, MPH, FACP, System Vice President, Clinical Standards and Variation Reduction, Physician EnterpriseDr. Jessica Croley, Medical Oncologist, Co-lead OCI Breast Clinical Council, CHI St. JosephWatch other cancer screening videos here:Cancer Screening Overview: https://www.youtube.com/watch?v=VESsQ...Lung Cancer Screening: https://youtu.be/5czY2s3PblY?si=KdhYG...Colorectal Cancer Screening: https://youtu.be/CxJbXdGQCQU?si=88oIn...

Learning Objectives:- Differentiate between usual care, palliative care, and hospice care- Identify patients who may benefit from palliative care or hospice- Discuss outcome data supporting early palliative care intervention- Describe opportunities for integrating palliative care into the management of the patient with serious illnessSpeakers:Dr. Paige Farinholt, Hospice and Palliative Medicine, CHI St. Luke's Health; Assistant Professor Hematology and Oncology, Baylor College of MedicineDr. Mark Beiter, Palliative Medicine, Virginia Mason Franciscan HealthPanelists:Sara Powers, NP, Adult Health Wound Care and Palliative Medicine, Mercy Regional Medical CenterDr. Anne C. RossignoDr. Gary Greensweig, Chief Physician Executive, Physician Enterprise

Learning Objectives:- Discuss the barriers and the necessary resources required for successful rapid up-titration of GDMT - Recognize the appropriate timing for referral of patients with advanced heart failure for percutaneous/surgical intervention- Understand indications/contraindications for HF patients requiring advanced therapies (i.e., transplant or mechanical circulatory support)- Recognize the current advanced non-medical therapy available for heart failure patients- Anticipate future advancements in non-medical therapy on the brink of mainstreamSpeakers:Selma Mohammed, MBBS, Advanced Heart Failure and Transplant Cardiology, CHI HealthKenneth Liao, MD, PhD, FACS, Professor and Chief, Cardiothoracic Transplantation and Circulatory Support, Baylor College of MedicinePanelists:Andrew Civitello, MD, FACC, Associate Professor, Cardiology, Medical Director, Heart Transplant Program, Baylor College of MedicineAlexis Edward Shafii, MD, FACS, Associate Professor of Surgery, Cardiothoracic Transplant and Circulatory Support, Baylor of Medicine

In this episode of clinical mythbusting, we're taking a look at two commonly held health beliefs and comparing them to the evidence:* Do we really need to drink so much water?* Is a vegetarian or vegan diet healthy?Watch and see what the evidence shows. See the first Mythbusting Episode: https://youtu.be/dU1eW-r_wH8?si=tscRd6EQ7L6S8DAJ

In honor of March as Colorectal Cancer Awareness Month, we are taking a closer look at our updated colorectal cancer screening guidelines, including risk-based screening, engaging patients, the best approach to screening, incidence and prevalence by age group (including rising incidence with younger patients) and more.Guests: Ankita Sagar, Devi Mukkai-Krishnamurty Colorectal Surgeon, Associate Professor, Creighton University School of MedicinePlease see our other videos about cancer screening:Cancer Screening Overview: https://youtu.be/VESsQIpgwlE?si=BgzNZI1huWpUMO4zLung Cancer Screening: https://youtu.be/5czY2s3PblY?si=Obtw6adw9DxlfivF

Learning Objectives:Define the key pharmacologic therapies for HFrEH and HFpEF and describe their optimal use in specific patient populationDiscuss the barriers and the necessary resources required for successful rapid up-titration of GDMTIdentify how improvement in medical therapy influences patient outcomes, including hospitalizations, re-admissions, and mortalitySpeakers:Biykem Bozkurt, MD, PhD, Professor of Cardiology, Baylor College of MedicineSelma Mohammed, MBBS, Advanced Heart Failure and Transplant Cardiology, CHI HealthPanelists:Joseph Rogers, MD, President and Chief Executive Officer, Texas Heart InstituteJessica Brown, MD, Cardiology and Heart Failure Specialist, Baylor St. Luke's Medical Group Woodlands North Houston Heart CenterModerator:Reza Ardehali, MD, Ph.D., FAHA, Professor and Chief of Cardiology, Baylor College of Medicine

Guests: Dr. Ankita Sagar, System VP for Clinical Standards and Variation Reduction and Dr. Suchitra Pilli, Interventional Pulonologist and Critical Care, Creighton University School of MedicineDiscussed: updated lung cancer screening guidelines including the move to risk-based screening, screening criteria recommendations, integrating the criteria into the process of care, and follow-up to positive screenings. Also covered: ways in which we're leveraging technology to identify patients eligible for lung cancer screening.Related podcasts:5-Minute Check In Lung, Breast, and Colon Cancer Screening Overview: https://www.buzzsprout.com/1903646/episodes/14402059Lung Cancer Screening Based on Risk Stratification Grand Rounds: https://www.buzzsprout.com/1903646/episodes/14144736

Learning Objectives:- Define the clinical definition of HFrEF, HFmidREF, and HFpEF- Describe the current epidemiology, economic burden, and quality standards- Explain the underlying pathophysiology of HFrEF and HFpEF with associated signs and symptomsSpeakers:Ajith P. Nair, MD, FACC, FAHA, Assistant Professor, Cardiology, Baylor College of MedicineNikolaos A. Diakos, MD, PhD, Interventional Cardiologist and Heart Failure Specialist, Texas Heart InstitutePanelists:Jessica Brown, MD, Cardiology and Heart Failure Specialist, Baylor St. Luke's Medical Group Woodlands North Houston Heart CenterModerator:John A. Flynn, MD, MBA, MEd, System Senior Vice President, Physician Enterprise, CommonSpirit Health, Texas

In this 5-minute check in we're reviewing how CommonSpirit has created streamlined preventative screening algorithms for lung, breast, and colon cancer.Issues addressed include: - Updated and simplified guidelines: changes we've made using best available evidence         - Combining USPSTF and NCCN         - Why we're shifting from age- to risk-based screening- Future state: clinical decision support and embedding into the EMR- Automation: Our focus on making screening more efficient, providing the support to help ensure providers are spending their valuable time in the right placesIn the coming weeks, we will do a deep dive into each topic and guidelines.

Learning Objectives:Discuss updates in medical weight lossIdentify ongoing barriers to weight loss managementSpeakers:Layla A. Abushamat, MD, MPH, Assistant Professor, Baylor College of MedicineMahmuda Tasneem, MD, Internal Medicine and Obesity Medicine, Virginia Mason Franciscan HealthPanelists:Anila Chadha, MD, Obesity Medicine Specialist, Dignity Health Medical Group — BakersfieldThu Le, PharmD, Clinical Pharmacist, Dignity HealthErin Sharp, PharmD, System Director Retail Pharmacy Services, CommonSpirit Health.

The FDA has approved the first cell-based gene therapies for sickle cell disease. In this extended episode, Dr. McGinn is joined by Creighton Geneticist and Bioethicist Fr. Kevin FitzGerald and Dr. Ankita Sagar, System Vice President for Clinical Standards and Variation Reduction, to dive into this significant milestone.Together they discuss CRISPR technology, treatment strategies, bioethics, and what this means for patients and providers alike in our battle against this devastating disease. Read more: https://www.fda.gov/news-events/press...

Guest: Dr. Christopher Huerter, Professor and Division Chief Dermatology at Creighton University School of MedicineBreakthrough treatments: Checkpoint inhibitors like Ipilimumab have changed the way we treat melanoma. Now, a new cutting-edge adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) has shown promise in metastatic melanoma treatment trials. A new phase III trial compares TIL to Ipilimumab immunotherapy as first- or second-line treatment in patients with advanced melanoma with remarkable results.Article:  https://www.nejm.org/doi/full/10.1056/NEJMoa2210233

Learning Objectives:Promoting evidence-based cancer screening and prevention strategiesUnderstanding risk factors related to eligibility for lung cancer screeningIdentifying the key aspects of a successful lung cancer screening programRecognizing the ways in which technology can be leveraged for identifying patients eligible for lung cancer screeningSpeakers:Suchitra Pilli, MD, Pulmonary Medicine, Interventional Pulmonology, CHI Health Omaha NebraskaPanelists:Misho Hubka, MD, Thoracic Surgeon, Medical Director, Virginia Mason Cancer Center and head of Thoracic surgery programPeter Emanuel, MD, Vice President of Oncology, CommonSpirit Health Oncology Clinical InstituteJohn D. Chelico, MD, MA, FACP, FAMIA, System Chief Medical Information Officer

What does the winter virus season have in store? Dr. McGinn and Dr. Vivekanandan (Division Chief, Infectious Disease and Professor at Creighton School of Medicine) look at the winter virus trends including where we currently are and what to expect this season with COVID, Influenza, RSV and pneumonia. They also discuss the so-called "White Lung" syndrome, a recent pneumonia outbreak making headlines, and whether there is any cause for concern.

Dr. Thomas McGinn and cardiac electrophysiology expert Dr. Arash Aryana focus on afib and the use of ablation, including a new randomized controlled trial that compares the success of Pulmonary Vein Isolation (PVI) against PVI plus Posterior Wall Isolation (PWI) using the posterior "Box" isolation approach. Dr. McGinn and Dr. Aryana discuss: PVI vs. PVI + PWI and whether there is a significant difference in resultsWhether the data supports posterior “box” isolation as a preferred strategyA comparison of "box" vs. "direct" posterior wall ablation methods 

Learning Objectives:-Promoting evidence-based cancer screening and prevention strategies-Discerning between patients with average, below average, and above average risk-Recognizing the differences between modalities available for colorectal cancer screeningSpeakers:-Devi Mukkai Krishnamurty, MBBS, Colorectal Surgery, General Surgery, CHI Health Omaha Nebraska-Ron Gagliano, MD, Colorectal Surgeon, Chair, Surgery DHMG, and Associate CMO for the Dignity Health Cancer Institute in PhoenixPanelist:Peter Emanuel, MD, Vice President of Oncology, CommonSpirit Health Oncology Clinical Institute

Learning Objectives:Promoting evidence-based cancer screening and prevention strategiesDiscerning between patients with average, below average, and above average riskRecognizing the differences between imaging modalities available for breast cancer screeningSpeakers:Jessica Croley, MD, Breast Medical Oncologist, OCI Breast Clinical Council LeadPeter Eby, MD, FSBI, FACR, Section Head of Breast Imaging, Virginia Mason Medical CenterJamie Hui, MD, Radiologist in Breast Imaging, Virginia Mason Franciscan HealthPanelists:Peter Emanuel, MD, Vice President of Oncology, CommonSpirit Health Oncology Clinical Institute

Myth vs. Fact: New series on mythbusting, comparing the culture of medicine with the evidence. Dr. Thomas McGinn and Dr. Ankita Sagar, System VP for Clinical Standards and Variation Reduction, tackle two commonly held beliefs and compare them to the data: 1) Statins and whether they cause muscle aches 2) Fasting before labs

New Guidelines for Asthma Management and Changes in Biologics featuring Dr. Rajan Merchant, Allergy, Asthma, and Clinical Immunology Specialist at Woodland Clinic. Discussed: 1) key recommendations for primary care from the Global Initiative for Asthma (GINA) update and 2) S.M.A.R.T. (Single Maintenance and Reliever Therapy 3) BiologicsArticles referenced: https://www.nature.com/articles/s41533-023-00330-1https://erj.ersjournals.com/content/early/2019/12/12/13993003.01872-2019.article-info

Learning Objectives:Review best practices in screening for suicidal ideationIllustrate strategies for addressing suicidality in primary care using standard suicide risk scalesSpeaker:Jonathan DeHaan, MD, Psychiatry, Virginia Mason Franciscan Health Medical GroupAndrew Trindle, LICSW, Manager, Outpatient Behavioral Health, Virginia Mason Hospital and Seattle Medical Center

Learning Objectives:- Describe the epidemiology of depression among adults- Discuss the assessment of depression among adults- Enumerate the treatments for depression among adultsSpeakers:Rajesh Tampi, MD, Professor and Chairman, Department of Psychiatry, Bhatia Family Endowed Chair in Psychiatry, Creighton University School of MedicinePanelists:Debra Rockman, RN, MBA, CPHRM, CPHQ,  System VP, Ambulatory QualityMonique Díaz, MD, Chief Medical Information Officer, Physical Medicine and Rehabilitation

Learning Objectives:- Review best practices in screening and diagnosis- Illustrate treatment strategies- Identify and strategize to overcome common challengesSpeaker:Jyotsna Ranga, MD, FAPA, DFAACAP, Associate Professor of Medicine at Creighton University School of Medicine, Program Director of Psychiatry Residency and Child/Adolescent Fellowship Programs at Creighton University, Vice Chair Child and Adolescent PsychiatryPanelists:Scott Piazza, DO, Medical Director of Informatics, Pacific Central Coast Health Centers, Faculty, Marian Family Medicine Residency ProgramMichael Dudas, MD, Chair of Pediatric Ambulatory Collaborative Steering Committee, Chief of Pediatrics, Deputy Chief of Primary Care, Virginia Mason Franciscan Health

Dr. Vivekanandan and Dr. Hotez join Dr. McGinn for a deep dive discussion on RSV including vaccine strategy; options for infants, pregnant women and seniors; benefits vs. risks; and why people who qualify should get the RSV vaccine. Guests: Dr. Renuga Vivekanandan, Division Chief, Infectious Disease, Creighton School of Medicine Dr. Peter Hotez, Professor and Dean National School of Tropical Medicine at Baylor College of Medicine and Co-Director Texas Children's Hospital Center for Vaccine Development

FDA says Popular Decongestant is Ineffective and the Impact of Coffee on Arrhythmia Guest: Dr. Kavita Chawla, Chair - EBM Education Committee, Internal Medicine, Virginia Mason Franciscan HealthArticles referenced: https://www.nejm.org/doi/full/10.1056/NEJMoa2204737In this 5-minute check in, Dr. McGinn and guest Dr. Kavita Chawla review two health care topics making headlines: An F.D.A. panel says a common decongestant found in many over-the-counter cold medicines is ineffective. Dr. McGinn and Dr. Chawla discuss the findings and what this means for patients. The “CRAVE” trial (Coffee and Real-time Atrial and Ventricular Ectopy) published in the NEJM studies the short term impact of caffeine on palpitations in relatively healthy people. Dr. McGinn and Dr. Chawla review the impact of coffee on PACs, PVCs as well as on step counts and sleep.

Dr. Thomas McGinn discusses what to expect for Fall viruses and their respective vaccinations this year.

Discusses appropriate use of pronouns and terminology to be utilized in communication with members of the LGBTQ+ community in an inclusive and equitable manner, in keeping with the values and ethics of health care delivery.Speakers:Dr. Mark Goodman, Creighton University School of Medicine, American Academy of HIV Medicine SpecialistDr. Michael A. Green, Program Director, Creighton University, Department of Family Medicine Joshua Lumsden, PA-C, Internal Medicine Physician Assistant, LGBTQ Health

Guests: Dr. Ankita Sagar, System VP for Clinical Standards and Variation Reduction, Physician Enterprise and Dr. Nick Stine, System SVP Population Health, Physician Enterprise.Overview: Screening and Treatment of Hepatitis C. CommonSpirit Health is pioneering clinical standards in the treatment of Hepatitis C to ensure our physicians and APPs are equipped with the necessary tools to identify and treat positive cases. During this 5-minute check in we discuss this important topic including:- Advancements and breakthroughs in treatment- Updated guidelines and resources available (including pharmacy and virtual screening tool)- The imperative to screen all adult patients at least once in their lifetimeWatch the Grand Rounds for an in depth conversation on this important topic with system experts covering screening, management, treatment, and our virtual screening tool through Baylor St. Luke's Project ECHO program. https://www.youtube.com/watch?v=4LceAEdoTcEPreview of upcoming topics:Flu/RSV/COVIDAsthmaMythbustingIn the headlines: Coffee consumption and impact on health as well as FDA panel says a common decongestant is ineffective

This session will encompass an overview of the management of Hepatitis C in primary care and subspecialty medicine.Dr. Justin Reynolds will review the basic principles of managing Hepatitis C, screening methodologies for advanced fibrosis in Hepatitis C patients, and the framework for initiating treatment with direct-acting antiviral (DAA) regimens.Dr. Saira Khaderi will present insights into the Baylor St. Luke's Project ECHO program, which facilitates coaching for primary care physicians and APPs across Texas and CommonSpirit Health, focusing on effective Hepatitis C patient management through virtual case-based discussions.Dr. Erin Sharp and Dr. Nicholas Stine will engage in a thoughtful panel discussion regarding the importance and feasibility of treating Hepatitis C within our communities.

The objectives of the presentation include:By the end of the presentation, participants will be able to compare and contrast oral and injectable forms of pre-exposure prophylaxis (PrEP) for HIV prevention, identifying their respective safety profiles, efficacy, and potential advantages or limitations.Following the presentation, participants will be able to discuss the importance of medication adherence in PrEP effectiveness, and develop strategies to promote and support adherence among patients.At the conclusion of the presentation, participants will be able to describe the guidelines for prescribing PrEP, including assessing sexually active patients, conducting baseline laboratory testing, and implementing ongoing assessments to ensure patient safety and optimal outcomes.By the end of the presentation, participants will be able to identify different methods of covering the cost of PrEP, including insurance coverage and pharmaceutical patient assistance programs, and provide guidance to patients on accessing financial resources to support PrEP utilization.Speakers:Paul Lovely, MHL, Executive Director CARE CenterBenjamin Lomeli, Biomedical Prevention Services CoordinatorChristine Gutierrez, NP, CARE CenterMarcia Alcouloumre, MD, Medical Director CARE Program